Nachrichten zur Emergent Biosolutions Inc. Aktie

Emergent BioSolutions receives $50 million contract option from BARDA

…

Why Emergent BioSciences Stock Plummeted Today

Emergent BioSolutions (NYSE: EBS) saw its shares tumble on Tuesday, due to news of a share sell-off. The vaccine maker…

Emergent BioSolutions Aktie legt kräftig zu - CEO Joe Papa sieht profitables Wachstum - Kaufen!

Kulmbach (www.aktiencheck.de) - Emergent BioSolutions-Aktienanalyse von "Der Aktionär": Michael Diertl vom Anlegermagazin "Der Aktionär" nimmt die Aktie von Emergent BioSolutions Inc.…

Emergent BioSolutions: Akien-Report-Tipp springt zweistellig an

Einen Kurssprung von rund 20 Prozent hat Emergent BioSolutions am Donnerstag hingelegt. Der Grund dafür waren deutlich besser als erwartete…

Emergent BioSolutions (EBS) Q3 2024 Earnings Call Transcript

EBS earnings call for the period ending September 30, 2024.…

Emergent BioSolutions Demonstrates Commitment to Increasing Access & Awareness of NARCAN® Nasal Spray to Help Combat the Opioid Epidemic

GAITHERSBURG, Md., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) remains committed to supporting widespread…

Emergent BioSolutions Aktie: Kursrutsch trotz Erholungsversuchen

Die Aktie von Emergent BioSolutions verzeichnete in den letzten Wochen einen deutlichen Kursrückgang. Trotz zwischenzeitlicher Erholungsversuche notiert der Titel aktuell…

Emergent BioSolutions Aktie: Erholung nach starkem Kurseinbruch

Der US-Impfstoffhersteller Emergent BioSolutions verzeichnet eine bemerkenswerte Erholung an der Börse. Nach einem dramatischen Kurssturz im vergangenen Jahr konnte die…

Emergent BioSolutions Awarded Research and Development Option valued at $41.9 Million for continued Advanced Development and Procurement of Ebanga™ Treatment for Ebola

GAITHERSBURG, Md., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it was awarded…

OHA is Administrative Agent and Sole Lender for Emergent BioSolutions Debt Refinancing

New York, New York, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Oak Hill Advisors (“OHA”) served as Administrative Agent…

Emergent BioSolutions: Unbekannter Lebensretter

Der Fentanyl-Missbrauch ist in den USA in den letzten Jahren zu einem riesigen Problem geworden. Eine Lösung dafür gibt es…

Emergent BioSolutions: Unbekannter Lebensretter

Der Fentanyl-Missbrauch ist in den USA in den letzten Jahren zu einem riesigen Problem geworden. Eine Lösung dafür gibt es…

Emergent BioSolutions: Positive News von der FDA - Aktienanalyse

Kulmbach (www.aktiencheck.de) - Emergent BioSolutions-Aktienanalyse von "Der Aktionär": Michael Diertl vom Anlegermagazin "Der Aktionär" rät weiterhin zum Kauf der Aktie von…

Emergent BioSolutions: FDA sorgt für Blitzstart

In der dieswöchigen Ausgabe 36/24 hat DER AKTIONÄR zum Kauf der Biotech-Aktie Emergent Biosolutions geraten.…

Emergent BioSolutions Finalizes Sale of Baltimore-Camden Manufacturing Site to Bora Pharmaceuticals

GAITHERSBURG, Md., Aug. 20, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has completed the…

Emergent BioSolutions Responds to Mpox Public Health Emergency as Cases Surge in Africa

GAITHERSBURG, Md., Aug. 19, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE: EBS) today announced it is proactively working…

Emergent Leads Mpox-Tied Stock Gains as Investors Await Approval

Emergent BioSolutions Inc. led an advance in the stocks of companies working on vaccines and antiviral products this week as…

Why Emergent BioSolutions Stock Is Skyrocketing Today

Concerns about the mpox outbreak are causing Emergent BioSolutions shares to jump.…

Emergent BioSolutions (EBS) Q2 2024 Earnings Call Transcript

EBS earnings call for the period ending June 30, 2024.…

Emergent BioSolutions Inc. (EBS) Q2 2024 Earnings Call Transcript

…

Emergent BioSolutions plunges 37% on Q2 EPS miss, wider projected 2024 net loss

…

Emergent BioSolutions Inc. 2024 Q2 - Results - Earnings Call Presentation

…

Emergent BioSolutions Reports Second Quarter 2024 Financial Results

GAITHERSBURG, Md., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for…

SERB Pharmaceuticals strengthens leadership in medical countermeasures with the global acquisition of RSDL® (Reactive Skin Decontamination Lotion) kit for $75 million

Philadelphia, PA, July 31, 2024 (GLOBE NEWSWIRE) -- SERB Pharmaceuticals, a global specialty pharmaceutical company, announced today the…

Emergent BioSolutions Launches Opioid Emergency Preparedness ‘Lay, Spray, Stay’ Public Education Campaign Starring Pro Football Hall of Famer Emmitt Smith

GAITHERSBURG, Md., July 24, 2024 (GLOBE NEWSWIRE) -- Today, Emergent BioSolutions Inc. (NYSE: EBS) announced the launch of…

Emergent BioSolutions Continues Driving Progress Against the Opioid Epidemic & Recognizes National Naloxone Awareness Day

GAITHERSBURG, Md., June 06, 2024 (GLOBE NEWSWIRE) -- In recognition of National Naloxone Awareness Day, Emergent BioSolutions Inc.…

Emergent BioSolutions: High-Risk, High-Reward Strategic Turnaround

…

Emergent BioSolutions to Hold Virtual Annual Meeting of Stockholders on Thursday, May 23, 2024

GAITHERSBURG, Md., May 10, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that its 2024 Annual…

Emergent BioSolutions gains as results top estimates, co to cut 300 jobs

…

Emergent BioSolutions (EBS) Q1 2024 Earnings Call Transcript

EBS earnings call for the period ending March 31, 2024.…

Emergent BioSolutions Inc. (EBS) Q1 2024 Earnings Call Transcript

…

Emergent BioSolutions Inc. 2024 Q1 - Results - Earnings Call Presentation

…

Emergent BioSolutions Reports First Quarter 2024 Financial Results

GAITHERSBURG, Md., May 01, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for…

Emergent BioSolutions Releases New Survey Findings Underscoring the Need to Continue Expanding Access & Increasing Awareness to Naloxone

GAITHERSBURG, Md., May 01, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced the results of…

Emergent BioSolutions Announces Amendment to its Existing Credit Facility

GAITHERSBURG, Md., April 30, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced that it has entered into…

Emergent BioSolutions Receives NAI Status for Baltimore Bayview Manufacturing Facility

GAITHERSBURG, Md., March 25, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced that the U.S. Food and…

Global Recombinant Vaccine Market Size To Exceed USD 24.9 Billion By 2032 | CAGR of 11.75%

The Global Recombinant Vaccine Market Size was Valued at USD 8.2 Billion in 2023 and the Worldwide Recombinant Vaccine Market…

Emergent BioSolutions (EBS) Q4 2023 Earnings Call Transcript

EBS earnings call for the period ending December 31, 2023.…

Emergent BioSolutions Inc. (EBS) Q4 2023 Earnings Call Transcript

…

Emergent BioSolutions Inc. 2023 Q4 - Results - Earnings Call Presentation

…

Emergent BioSolutions Reports Fourth Quarter 2023 Financial Results

GAITHERSBURG, Md., March 06, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for…

Emergent BioSolutions appoints new CEO to drive growth By Investing.com

Emergent BioSolutions appoints new CEO to drive growth…

Emergent BioSolutions extends shelf life of Narcan to 4 years

…

Emergent BioSolutions to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 11, 2024

GAITHERSBURG, Md., Jan. 09, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE: EBS), a global company providing solutions that…

Emergent BioSolutions stock pulls back, after rallying last week in wake of Biden administration’s endorsement of overdose medications

…

dpa-AFX ProFeed